Last week, This week

Nice consolidation last week in double digits and good to see LCT fairing so well on NY exchange 36th of 500 on that listing so will gain visibility and interest there.
Looking forward to the week ahead now and surely an announcement from Medical Board confirming or otherwise that the stage 2 double dosage patience are all ok and clearance for the final stage triple dosage. Certainly running out of time for LCT to complete that stage 3 within the next 4 weeks to plan if they don't get the go ahead this week. I assume patients are already scheduled on basis of that forecast being granted. Could we even hope for a Living Insights news letter as well?. The safety "ok" from that double dosage both sides of the brain would be a major new step forward . Actually every patient who has no adverse reaction from the procedure is another positive for Immupel Technology which is possibly the somewhat undervalued clinical asset that LCT both developed and own. Not wishing to build the week up too much as each week from now on is probably more important than the last. However good we are now into "weeks" though not "years" after all this time. Good luck all, patients and holders.!